Report Overview

The EU Crohns Disease market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Crohn's disease is an inflammatory bowel disease (IBD). It causes inflammation of the digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. Crohns disease is caused by a combination of factors involving genetics, the environment, and an overactive immune system. It is not caused by something you ate or your diet. Crohns disease has been affecting the Western European countries more heavily than others



Market Drivers

The increasing prevalence of inflammatory bowel disease (IBD) is one of the key factor driving the Crohns disease therapeutics market. Rising patient population due to lifestyle changes and other factors also contributes to the expansion of the market. The market growth can be attributed to the presence of a well-established healthcare system and increasing initiatives by government bodies for the development of new treatment options and is estimated to provide the market with high growth potential